Disease/Infection News

RSS

Study finds immunity against SARS-CoV-2 delta variant waned after BNT162b2 vaccine second dose

Researchers from Israel have investigated the possibility that vaccine-induced immunity reduces over time and potential causes and risk factors.

29 Oct 2021

SARS-CoV-2 incidence and mortality in US school opening model

Researchers reported regional variations on the impact of school reopening policy on the community rate of SARS-CoV-2 infection.

29 Oct 2021

Causal effect of school closures on reducing COVID-19 spread in Japan

A new study estimated the causal effect of school closures on reducing the spread of COVID-19.

29 Oct 2021

The role of CRISPR in viral diagnostics

A comprehensive review explains in depth how CRISPR can be utilized as a reliable tool to investigate the viral life cycles.

29 Oct 2021

Study finds early fluvoxamine treatment among COVID-19 patients reduces hospitalization

A team of researchers conducted a randomized, placebo-controlled, adaptive platform trial to evaluate the efficacy of fluvoxamine to prevent COVID-19 progression and hospitalization.

29 Oct 2021

Many students urged to join in COVID-19 screening program to help keep Cambridge safe

An estimated 7,000 students are already taking part each week in the University of Cambridge's Asymptomatic COVID-19 Screening Programme, but the team running the program are encouraging as many students as possible to join in, and help keep Cambridge safe.

28 Oct 2021

Study uncovers unknown effects of COVID-19 virus on the immune system

COVID-19 reduces the numbers and functional competence of certain types of immune cells in the blood, say LMU researchers. This could affect responses to secondary infections.

28 Oct 2021

Unique breath test is highly accurate in identifying COVID-19 in critically ill patients

Instead of an invasive nasal swab, researchers at The Ohio State University Wexner Medical Center are exploring the use of a unique breath test for the rapid screening of patients for COVID-19.

28 Oct 2021

More strategic COVID-19 testing can reduce reliance on costly preventative interventions

Strategically increasing testing capacity, either by making diagnostic tests faster or more available, can reduce reliance on costly preventative interventions, such as distancing and shutdowns, according to a team of researchers led by Penn State.

28 Oct 2021

Breakthrough COVID infections in Northeast Italy showing waning vaccine protection

Researchers analyze an outbreak of breakthrough infections in a small nursing home in Northerneastern Italy.

28 Oct 2021

How long does natural or vaccine-induced immunity to COVID last?

Researchers present a comprehensive assessment on SARS-CoV-2 induced immunity.

28 Oct 2021

Importance of boosters after priming with J&J Ad26.COV2.S COVID-19 vaccine

A new study compares healthcare workers who underwent homologous Ad26.COV2.S booster vaccination to those who underwent heterologous boosting.

28 Oct 2021

A novel approach to improve the stability of Remdesivir

A recent study discusses a novel method to enhance the stability of Remdesivir.

28 Oct 2021

Study suggests third dose of the Pfizer vaccine could reduce SARS-CoV-2 transmission

A new study examined protection against symptomatic coronavirus disease 2019 (COVID-19) from non-Delta variants using data from randomized control trials.

28 Oct 2021

Understanding and predicting COVID-19 vaccination willingness of New Zealanders

The current study implemented the I3 Framework to determine the willingness of New Zealanders to be vaccinated against COVID-19.

28 Oct 2021

Structure of human-infecting canine coronavirus HuPn-2018 spike glycoprotein

As CCoV-HuPn-2018 has been recently isolated in a child's respiratory swab, researchers from the University Of Washington have been examining the structure of the virus.

28 Oct 2021

Malaria: An Interview with the World Health Organization

In this interview, we spoke to Dr. Akpaka Kalu, the World Health Organization's team leader for malaria in Africa, about the groundbreaking malaria vaccine rollout announcement.

28 Oct 2021

Study finds one mRNA vaccine dose after SARS-CoV-2 infection produces highest neutralizing antibody titers

Researchers investigated the neutralizing antibody response that different mRNA vaccines induce in both previously convalescent and SARS-CoV-2 naïve individuals.

28 Oct 2021

Panel of broadly neutralizing SARS-CoV-2 nanobodies for immune assay application

In this study, a team of researchers from Japanese institutions provide a panel of broadly neutralizing nanobodies that detect four VOCs.

28 Oct 2021

Two-dose SARS-CoV-2 vaccine effectiveness against infection and hospitalization in Canada

Authors from varying Canadian institutes report on two-dose vaccine effectiveness against infection and hospitalization.

28 Oct 2021

Disease/Infection News

Study finds immunity against SARS-CoV-2 delta variant waned after BNT162b2 vaccine second dose

SARS-CoV-2 incidence and mortality in US school opening model

Causal effect of school closures on reducing COVID-19 spread in Japan

The role of CRISPR in viral diagnostics

Study finds early fluvoxamine treatment among COVID-19 patients reduces hospitalization

Many students urged to join in COVID-19 screening program to help keep Cambridge safe

Study uncovers unknown effects of COVID-19 virus on the immune system

Unique breath test is highly accurate in identifying COVID-19 in critically ill patients

More strategic COVID-19 testing can reduce reliance on costly preventative interventions

Breakthrough COVID infections in Northeast Italy showing waning vaccine protection

How long does natural or vaccine-induced immunity to COVID last?

Importance of boosters after priming with J&J Ad26.COV2.S COVID-19 vaccine

A novel approach to improve the stability of Remdesivir

Study suggests third dose of the Pfizer vaccine could reduce SARS-CoV-2 transmission

Understanding and predicting COVID-19 vaccination willingness of New Zealanders

Structure of human-infecting canine coronavirus HuPn-2018 spike glycoprotein

Malaria: An Interview with the World Health Organization

Study finds one mRNA vaccine dose after SARS-CoV-2 infection produces highest neutralizing antibody titers

Panel of broadly neutralizing SARS-CoV-2 nanobodies for immune assay application

Two-dose SARS-CoV-2 vaccine effectiveness against infection and hospitalization in Canada

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News